Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
We provide 1 form of Acalabrutinib
Acalabrutinib
1420477-60-6
|
465.507
|
1.581
Acalabrutinib is an orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. It prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. It also plays an important role in B lymphocyte development, activation, signaling, proliferation and survival.
ACP-196 | acalabrutinib | calquence
Acalabrutinib is an orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. It prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. It also plays an important role in B lymphocyte development, activation, signaling, proliferation and survival.
ACP-196 | acalabrutinib | calquence
$50/5 mg
(EBC)
1
We provide 0 compound for Acalabrutinib
Powered by Bioz